TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNFA" or the "Company"), a clinical stage biopharmaceutical company committed to ...
BioSpace6h
2025 Investment to Swing Toward I&I, Obesity, More: Experts
As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...
BioSpace4h
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.
Le Lézard9h
Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year
As 2025 begins, the American Association for Cancer Research (AACR) recently published forecasts from experts showcasing transformative advances in cancer research, including cutting-edge AI ...